These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18637489)

  • 41. Peptides in body fluids and tissues as markers of disease.
    Schulte I; Tammen H; Selle H; Schulz-Knappe P
    Expert Rev Mol Diagn; 2005 Mar; 5(2):145-57. PubMed ID: 15833045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of oncoproteomics to cancer biomarker discovery.
    Cho WC
    Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Proteomics and biomarkers for detection of cervical cancer].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
    Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging nanoproteomics approaches for disease biomarker detection: a current perspective.
    Ray S; Reddy PJ; Choudhary S; Raghu D; Srivastava S
    J Proteomics; 2011 Nov; 74(12):2660-81. PubMed ID: 21596164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The therapeutic contribution of proteomic approaches in cancers].
    Hamrita B; Nasr HB; Kabbage M; Hamann P; Kuhn L; Guillier C; Remadi S; Chaieb A; Khairi H; Chouchane L; Chahed K
    Gynecol Obstet Fertil; 2011 Feb; 39(2):87-93. PubMed ID: 21317010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.
    Paul D; Kumar A; Gajbhiye A; Santra MK; Srikanth R
    Biomed Res Int; 2013; 2013():783131. PubMed ID: 23586059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue and plasma proteomics for early stage cancer detection.
    Peng L; Cantor DI; Huang C; Wang K; Baker MS; Nice EC
    Mol Omics; 2018 Dec; 14(6):405-423. PubMed ID: 30251724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomics biomarkers for solid tumors: Current status and future prospects.
    Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
    Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in proteomic prostate cancer biomarker discovery.
    Goo YA; Goodlett DR
    J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomics for Early Diagnostics.
    Mali SB
    J Craniofac Surg; 2015 Jun; 26(4):1013-4. PubMed ID: 26080113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptidomics of urine and other biofluids for cancer diagnostics.
    Bauça JM; Martínez-Morillo E; Diamandis EP
    Clin Chem; 2014 Aug; 60(8):1052-61. PubMed ID: 24212086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glioma proteomics: status and perspectives.
    Niclou SP; Fack F; Rajcevic U
    J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries.
    Boschetti E; D'Amato A; Candiano G; Righetti PG
    J Proteomics; 2018 Sep; 188():1-14. PubMed ID: 28882677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarker development, from bench to bedside.
    Stenman UH
    Crit Rev Clin Lab Sci; 2016; 53(2):69-86. PubMed ID: 26287282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.